Lucigen Raises $2.2M in Private Stock Placement | GenomeWeb

NEW YORK (GenomeWeb) – Lucigen has raised $2.2 million in a private financing round, its CEO confirmed to GenomeWeb today.

The Middleton, Wisc.-based firm disclosed the financing in a regulatory document filed with the US Securities and Exchange Commission this week. In an email, Lucigen Chairman and CEO Ralph Kauten said that the financing is an extension of a private stock placement completed in January that brought in $2 million. According to this week's SEC document, Lucigen is targeting $2.5 million in the round in total.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.